Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramkhamhaeng Hospital PCLBKK:RAM -0.56%77 EBITDA Margin % is 20.72% as of Mar. 2026, which is 46% below its 10-year median of 38.13. GuruFocus rates BKK:RAM with a GF Score™ of 77/100 and a GF Value™ of ฿45.41 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Ramkhamhaeng Hospital PCL ranks better than 92.94% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ramkhamhaeng Hospital PCL EBITDA Margin % Related Terms
Ramkhamhaeng Hospital PCL EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:RAM vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Ramkhamhaeng Hospital PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramkhamhaeng Hospital PCL EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramkhamhaeng Hospital PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ramkhamhaeng Hospital PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramkhamhaeng Hospital PCL (BKK:RAM) has a EBITDA Margin % of 20.72% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ramkhamhaeng Hospital PCL and its competitors. This is 46% below median its historical median of 38.13. Over the past decade, Ramkhamhaeng Hospital PCL's EBITDA Margin % has ranged from 23.81 to 69.01. According to the industry distribution chart, Ramkhamhaeng Hospital PCL ranks #47 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 7.1%.
Is Ramkhamhaeng Hospital PCL's EBITDA Margin % too high?
Ramkhamhaeng Hospital PCL's current EBITDA Margin % of 20.72% is 46% below median its 10-year median of 38.13. Over the past 10 years, this metric has ranged from a low of 23.81 to a high of 69.01. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Ramkhamhaeng Hospital PCL's value of 20.72% is 102.4% above this industry median. Based on the distribution chart, Ramkhamhaeng Hospital PCL ranks #47 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ramkhamhaeng Hospital PCL has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ramkhamhaeng Hospital PCL's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramkhamhaeng Hospital PCL ranks #47 out of 666 companies for EBITDA Margin %. This places Ramkhamhaeng Hospital PCL in the top 7% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.24. Ramkhamhaeng Hospital PCL's value of 20.72% is 102.4% above this benchmark. Historically, Ramkhamhaeng Hospital PCL's own EBITDA Margin % has ranged from 23.81 to 69.01 over the past decade. While the company's 10-year median is 38.13 vs. the industry median of 10.24, Ramkhamhaeng Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramkhamhaeng Hospital PCL's current EBITDA Margin % of 20.72% is 102.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ramkhamhaeng Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramkhamhaeng Hospital PCL's current EBITDA Margin % is 20.72%, which is 46% below median its own 10-year median of 38.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramkhamhaeng Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL (BKK:RAM) is currently considered Possible Value Trap. The stock's GF Value™ is ฿45.41, compared to a current price of ฿17.90 — trading 60.6% below its estimated fair value. The current EBITDA Margin % is 20.72%, which is 46% below median its 10-year median of 38.13 and 102.4% above the Healthcare Providers & Services industry median of 10.24. Ramkhamhaeng Hospital PCL's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ramkhamhaeng Hospital PCL (BKK:RAM), the current EBITDA Margin % is 20.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramkhamhaeng Hospital PCL (BKK:RAM) Overvalued in 2026?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL stock appears to be undervalued.
The current stock price of ฿17.90 is trading 60.6% below its estimated GF Value™ of ฿45.41.
GuruFocus considers Ramkhamhaeng Hospital PCL to be Possible Value Trap.
Key valuation signals for BKK:RAM:
EBITDA Margin %: 20.72% (46% below median its 10-year median of 38.13)
GF Value™: ฿45.41 vs. price of ฿17.90 (60.6% below fair value)
Industry Position: 102.4% above the Healthcare Providers & Services median (#47 of 666)
No single metric tells the full story. See the BKK:RAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramkhamhaeng Hospital PCL business activities are hospital and businesses that support medical care. The company provides medical treatment for all types of diseases by physicians and medical professionals in all specialties. Its medical services include the 24-hour Heart Center, RAM Pituitary Center for laparoscopic surgery for pituitary tumors, Neurology & Neurosurgery Center, and specialized medical centers such as Eye Clinic, Ear, Nose and Throat Clinic, Gastroenterology Clinic, Obstetrics and Gynecology Clinic, and Diabetes Clinic. The company operates through two segments: Hospital, which includes General Hospital and Hospital in Social Security and generates the maximum revenue; and Others, which includes sale of medical equipment and instruments. Its operations are in Thailand.
77GF Score
Get the complete analysis for BKK:RAM
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:RAM has been successfully added to your 
